The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is sponsoring two Proposers Day events in support of the Pandemic Prevention Platform (P3) program.
A Proposers Day will be held on February 22, 2017 in McLean, VA and another on March 2, 2017 in San Diego, CA.
The events aim to introduce the science and technology community to the P3 program vision and goals; facilitate interaction between investigators that may have capabilities to develop elements of interest and relevance to P3; and to encourage and promote teaming arrangements among organizations that have the relevant expertise or research facilities.
The goal of P3 is to achieve an integrated capability that can deliver pandemic prevention countermeasures to patients within 60 days of an outbreak. P3 aims to revolutionize outbreak response by enabling rapid discovery, characterization, production, and testing of efficacious medical countermeasures.
P3 will innovate in the following thrust areas:
- Generation of virus stock (including viral unknowns)
- Rapid evolution of antibody candidates
- Gene-encoded antibody delivery methods
Attendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities Page.
Advance registration is required. All attendees are required to present government-issued photo identification upon entry to the event. Non-US citizens are required to submit a DARPA Form 60 “Foreign National Visit Request,” which is available on the registration website.
Further details about the P3 program are available via Solicitation Number: HR001117S0019. The Broad Agency Announcement proposal abstract submission deadline is March 13, 2017 by 12:00 pm ET.
